| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/29/1997 | EP0813541A1 Process for producing a protein |
| 12/29/1997 | EP0813540A1 Bacterial catabolism of chitin |
| 12/29/1997 | EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/29/1997 | EP0813423A1 Composition to ameliorate osteolysis and metastasis |
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 12/29/1997 | EP0687305B1 Esterase and its use in biotransformation |
| 12/29/1997 | EP0672141A4 Methods of preparing soluble, oligomeric proteins. |
| 12/29/1997 | EP0666904B1 Attenuated strains of aeromonas salmonicida useful as fish vaccines |
| 12/29/1997 | EP0642305B1 NOVEL BACILLUS THURINGIENSIS ISOLATE DENOTED B.t.PS158C2, ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING LEPIDOPTERAN-ACTIVE TOXINS |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0610408B1 Heparinase gene from flavobacterium heparinum |
| 12/29/1997 | EP0561796B1 Dna amplification fingerprinting |
| 12/29/1997 | EP0552296B1 Mouse monoclonal antibodies |
| 12/29/1997 | EP0550678B1 Media for culture of drosophila cells |
| 12/29/1997 | EP0438512B1 Process for analysing length polymorphisms in dna domains |
| 12/24/1997 | WO1997048983A1 SCREENING COMPOUNDS FOR THE ABILITY TO ALTER THE PRODUCTION OF AMYLOID-β PEPTIDE (x-≥41) |
| 12/24/1997 | WO1997048982A1 A method for diagnosis and prognosis of cancer |
| 12/24/1997 | WO1997048977A2 Detection of ligand interaction with polymeric material |
| 12/24/1997 | WO1997048823A1 Method of screening foods for nutraceuticals |
| 12/24/1997 | WO1997048820A1 Promiscuous g-protein compositions and their use |
| 12/24/1997 | WO1997048819A1 Cassava vein mosaic virus promoters and uses thereof |
| 12/24/1997 | WO1997048815A2 Method for enhancing gene transfer |
| 12/24/1997 | WO1997048814A2 Methods for the production of stably-transformed, fertile wheat employing agrobacterium-mediated transformation and compositions derived therefrom |
| 12/24/1997 | WO1997048812A2 Dna sequences encoding phytases of ruminal microorganisms |
| 12/24/1997 | WO1997048811A1 Acyltransferase and gene encoding acyltransferase |
| 12/24/1997 | WO1997048810A1 Method of treating lactose intolerance |
| 12/24/1997 | WO1997048808A1 Bacterial production of interferon-beta using low levels of sodium and potassium ions |
| 12/24/1997 | WO1997048807A1 CHEMOKINE β-15 |
| 12/24/1997 | WO1997048806A1 Gene therapy for obesity |
| 12/24/1997 | WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF |
| 12/24/1997 | WO1997048804A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 12/24/1997 | WO1997048803A1 Human protein kinase c inhibitor homolog |
| 12/24/1997 | WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 12/24/1997 | WO1997048801A2 Polynucleotides encoding secreted proteins |
| 12/24/1997 | WO1997048800A1 Polynucleotides encoding secreted proteins from human pbmc |
| 12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | WO1997048798A1 Polynucleotide encoding secreted protein isolated from human dendritic cells |
| 12/24/1997 | WO1997048797A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 12/24/1997 | WO1997048796A1 A method for determining susceptibility to insulin dependent diabetes mellitus |
| 12/24/1997 | WO1997048795A2 Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
| 12/24/1997 | WO1997048794A1 Amidase |
| 12/24/1997 | WO1997048793A1 Plant sterol reductases and uses thereof |
| 12/24/1997 | WO1997048792A1 Transgenic non-human mammals with progressive neurologic disease |
| 12/24/1997 | WO1997048791A1 Direct cloning of dna fragments |
| 12/24/1997 | WO1997048790A1 Process for producing target substances by fermentation |
| 12/24/1997 | WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | WO1997048724A2 Human metabotropic glutamate receptor |
| 12/24/1997 | WO1997048723A2 Ptp-20, pcp-2, bdp1, clk and sirp proteins and related products |
| 12/24/1997 | WO1997048721A1 Hodgkin's disease associated molecules and uses thereof |
| 12/24/1997 | WO1997048720A1 Nucleic acid molecule for enhancing gene expression |
| 12/24/1997 | WO1997048719A1 Pheromone compositions and methods of use in controlling fungal diseases in plants |
| 12/24/1997 | WO1997048717A1 Production and use of normalized dna libraries |
| 12/24/1997 | WO1997048716A1 Method and kits for preparing multicomponent nucleic acid constructs |
| 12/24/1997 | WO1997048715A1 Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide |
| 12/24/1997 | WO1997048714A1 Chimeric mutational vectors having non-natural nucleotides |
| 12/24/1997 | WO1997048485A1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 12/24/1997 | WO1997048419A1 Gene therapy for obesity |
| 12/24/1997 | WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | WO1997048417A1 Vaccine to prevent streptococcal endocarditis |
| 12/24/1997 | WO1997048416A1 Thermostable phosphatases |
| 12/24/1997 | WO1997048415A1 Laminin-5 and the formation of basement membrane structure |
| 12/24/1997 | WO1997048370A2 Vaccines comprising synthetic genes |
| 12/24/1997 | WO1997048277A1 Modular assembly retroviral vectors and uses thereof |
| 12/24/1997 | WO1997048275A1 Endoderm, cardiac and neural inducing factors |
| 12/24/1997 | WO1997044488A3 Compositions and methods for the detection of mycobacterium kansasii |
| 12/24/1997 | WO1997044471A3 Potato plants with reduced cytosolic starch phosphorylasis and modified germination |
| 12/24/1997 | WO1997044456A3 Tumor virus susceptibility genes and gene products, and uses related thereto |
| 12/24/1997 | WO1997043404A3 Ribozyme variants with improved catalytic activity under low magnesium conditions |
| 12/24/1997 | WO1997042332A3 Genetically transformed cassava cells and regeneration of transgenic cassava plants |
| 12/24/1997 | WO1997041235A3 A NEW, PIGMENT-PRODUCING, STRAIN OF $i(BACILLUS THURINGIENSIS) |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997039122A3 Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof |
| 12/24/1997 | WO1997017454A3 COMMERCIAL PRODUCTION OF β-GLUCURONEDASE IN PLANTS |
| 12/24/1997 | CN1168705A A method of obtaining a cellulosic textile fabric with reduced tendency to pilling formation |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/24/1997 | CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 12/24/1997 | CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 12/24/1997 | CN1168696A RNA component of telomerase |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168679A Monoclonal antibody fragments having immunosuppressant activity |
| 12/24/1997 | CN1168678A Method of treating diabetes mellitus using KGF |
| 12/24/1997 | CN1168676A Materials for the production of nanometer structures and use thereof |
| 12/24/1997 | CN1168415A Coded DND of deaminated formylase capable of increasing heat resistance and its use |
| 12/24/1997 | CN1168414A Clone and expression cell line of erythropoietin gene |
| 12/24/1997 | CN1168413A Erythropoietin |
| 12/24/1997 | CN1036794C Variable region gene sequence of monoclonal antibody for resisting human activated blood platelet |
| 12/24/1997 | CA2294433A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | CA2259122A1 Novel ptp-20, pcp-2, bdp1, clk and sirp proteins and related products and methods |
| 12/24/1997 | CA2258824A1 Acyltransferase and gene encoding acyltransferase |
| 12/24/1997 | CA2258821A1 Method of screening foods for nutraceuticals |
| 12/24/1997 | CA2258789A1 Endoderm, cardiac and neural inducing factors |
| 12/24/1997 | CA2258755A1 Gene therapy for obesity |
| 12/24/1997 | CA2258573A1 Hodgkin's disease associated molecules and uses thereof |
| 12/24/1997 | CA2258571A1 Plant sterol reductases and uses thereof |
| 12/24/1997 | CA2258570A1 Method and kits for preparing multicomponent nucleic acid constructs |
| 12/24/1997 | CA2258568A1 Vaccines comprising synthetic genes |
| 12/24/1997 | CA2258526A1 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |